Review



prothrombin with gla domain removed  (Enzyme Research Laboratories)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Enzyme Research Laboratories prothrombin with gla domain removed
    Patient's profile demonstrating inverse correlation between <t>prothrombin</t> and antibody level. Clinical presentation (A) and protein profile (B, C) in patient's plasma at different sampling numbers shown as sampling no. 1–15 with corresponding dates. (A) Clinical presentation, (B) prothrombin was followed by activity measurements using one‐stage assay. Gray area indicates the reference range (0.80–1.30 kIU/L). (C) Nonneutralizing‐binding antibody titer was followed by prothrombin as coat in ELISA and shown as standard deviations (SD) above the mean from analyzing plasma samples from healthy donors. The gray area indicates the reference range (<3 SD).
    Prothrombin With Gla Domain Removed, supplied by Enzyme Research Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/prothrombin with gla domain removed/product/Enzyme Research Laboratories
    Average 90 stars, based on 1 article reviews
    prothrombin with gla domain removed - by Bioz Stars, 2026-05
    90/100 stars

    Images

    1) Product Images from "A nonneutralizing antibody as cause of prothrombin deficiency in a patient with follicular lymphoma"

    Article Title: A nonneutralizing antibody as cause of prothrombin deficiency in a patient with follicular lymphoma

    Journal: Clinical Case Reports

    doi: 10.1002/ccr3.8400

    Patient's profile demonstrating inverse correlation between prothrombin and antibody level. Clinical presentation (A) and protein profile (B, C) in patient's plasma at different sampling numbers shown as sampling no. 1–15 with corresponding dates. (A) Clinical presentation, (B) prothrombin was followed by activity measurements using one‐stage assay. Gray area indicates the reference range (0.80–1.30 kIU/L). (C) Nonneutralizing‐binding antibody titer was followed by prothrombin as coat in ELISA and shown as standard deviations (SD) above the mean from analyzing plasma samples from healthy donors. The gray area indicates the reference range (<3 SD).
    Figure Legend Snippet: Patient's profile demonstrating inverse correlation between prothrombin and antibody level. Clinical presentation (A) and protein profile (B, C) in patient's plasma at different sampling numbers shown as sampling no. 1–15 with corresponding dates. (A) Clinical presentation, (B) prothrombin was followed by activity measurements using one‐stage assay. Gray area indicates the reference range (0.80–1.30 kIU/L). (C) Nonneutralizing‐binding antibody titer was followed by prothrombin as coat in ELISA and shown as standard deviations (SD) above the mean from analyzing plasma samples from healthy donors. The gray area indicates the reference range (<3 SD).

    Techniques Used: Clinical Proteomics, Sampling, Activity Assay, Binding Assay, Enzyme-linked Immunosorbent Assay

    Routine and special coagulation assays in patient plasma indicate low prothrombin levels.
    Figure Legend Snippet: Routine and special coagulation assays in patient plasma indicate low prothrombin levels.

    Techniques Used: Coagulation, Clinical Proteomics, Sampling



    Similar Products

    prothrombin with gla domain removed  (Enzyme Research Laboratories)
    90
    Enzyme Research Laboratories prothrombin with gla domain removed
    Patient's profile demonstrating inverse correlation between <t>prothrombin</t> and antibody level. Clinical presentation (A) and protein profile (B, C) in patient's plasma at different sampling numbers shown as sampling no. 1–15 with corresponding dates. (A) Clinical presentation, (B) prothrombin was followed by activity measurements using one‐stage assay. Gray area indicates the reference range (0.80–1.30 kIU/L). (C) Nonneutralizing‐binding antibody titer was followed by prothrombin as coat in ELISA and shown as standard deviations (SD) above the mean from analyzing plasma samples from healthy donors. The gray area indicates the reference range (<3 SD).
    Prothrombin With Gla Domain Removed, supplied by Enzyme Research Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/prothrombin with gla domain removed/product/Enzyme Research Laboratories
    Average 90 stars, based on 1 article reviews
    prothrombin with gla domain removed - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Patient's profile demonstrating inverse correlation between prothrombin and antibody level. Clinical presentation (A) and protein profile (B, C) in patient's plasma at different sampling numbers shown as sampling no. 1–15 with corresponding dates. (A) Clinical presentation, (B) prothrombin was followed by activity measurements using one‐stage assay. Gray area indicates the reference range (0.80–1.30 kIU/L). (C) Nonneutralizing‐binding antibody titer was followed by prothrombin as coat in ELISA and shown as standard deviations (SD) above the mean from analyzing plasma samples from healthy donors. The gray area indicates the reference range (<3 SD).

    Journal: Clinical Case Reports

    Article Title: A nonneutralizing antibody as cause of prothrombin deficiency in a patient with follicular lymphoma

    doi: 10.1002/ccr3.8400

    Figure Lengend Snippet: Patient's profile demonstrating inverse correlation between prothrombin and antibody level. Clinical presentation (A) and protein profile (B, C) in patient's plasma at different sampling numbers shown as sampling no. 1–15 with corresponding dates. (A) Clinical presentation, (B) prothrombin was followed by activity measurements using one‐stage assay. Gray area indicates the reference range (0.80–1.30 kIU/L). (C) Nonneutralizing‐binding antibody titer was followed by prothrombin as coat in ELISA and shown as standard deviations (SD) above the mean from analyzing plasma samples from healthy donors. The gray area indicates the reference range (<3 SD).

    Article Snippet: Antiprothrombin‐binding (nonneutralizing) antibody titer was calculated with ELISA immunoassay using prothrombin, prothrombin with gla domain removed (Enzyme Research Laboratories, South Bend, USA), or Factor IX Benefix® (Pfizer, NY, USA) as coat at 5 μg/mL.

    Techniques: Clinical Proteomics, Sampling, Activity Assay, Binding Assay, Enzyme-linked Immunosorbent Assay

    Routine and special coagulation assays in patient plasma indicate low prothrombin levels.

    Journal: Clinical Case Reports

    Article Title: A nonneutralizing antibody as cause of prothrombin deficiency in a patient with follicular lymphoma

    doi: 10.1002/ccr3.8400

    Figure Lengend Snippet: Routine and special coagulation assays in patient plasma indicate low prothrombin levels.

    Article Snippet: Antiprothrombin‐binding (nonneutralizing) antibody titer was calculated with ELISA immunoassay using prothrombin, prothrombin with gla domain removed (Enzyme Research Laboratories, South Bend, USA), or Factor IX Benefix® (Pfizer, NY, USA) as coat at 5 μg/mL.

    Techniques: Coagulation, Clinical Proteomics, Sampling